Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amaya Gascó Hernández"'
Autor:
Rakesh Kumar, Amaya Gascó Hernández, Natalia Ceaicovscaia, Maozhen Gong, Delphine Lissa, Karl Fraser, Nicholas M. Durham, Emily C. Jennings, Sonia Agrawal, Lily I. Cheng, Mark T. Esser, Jean Boyer, Marcelo Bonomi, Mercedes Porosnicu, Missak Haigentz, Tanguy Y. Seiwert, Ammar Sukari, Alain Algazi, Nabil F. Saba, Charu Aggarwal
Supplementary Table S1. Representativeness of Study Participants Supplementary Table S2. Disease response as assessed by RECIST v1.1 by PD-L1 tumor cell expression (response-evaluable population). Supplementary Table S3. Disease response as assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad24f29865515292b62ff30864060b0
https://doi.org/10.1158/1078-0432.22490335.v1
https://doi.org/10.1158/1078-0432.22490335.v1
Autor:
Rakesh Kumar, Amaya Gascó Hernández, Natalia Ceaicovscaia, Maozhen Gong, Delphine Lissa, Karl Fraser, Nicholas M. Durham, Emily C. Jennings, Sonia Agrawal, Lily I. Cheng, Mark T. Esser, Jean Boyer, Marcelo Bonomi, Mercedes Porosnicu, Missak Haigentz, Tanguy Y. Seiwert, Ammar Sukari, Alain Algazi, Nabil F. Saba, Charu Aggarwal
Supplementary Figure S1. Patient disposition. Supplementary Figure S2. Association of PD-L1 expression and HPV status with best antitumor response. Supplementary Figure S3. Kaplan-Meier distribution curves for (A) PFS and (B) OS in the as-treated pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9a25141bab23dd8f6083cb326173c6
https://doi.org/10.1158/1078-0432.22490338.v1
https://doi.org/10.1158/1078-0432.22490338.v1
Autor:
Rakesh Kumar, Amaya Gascó Hernández, Natalia Ceaicovscaia, Maozhen Gong, Delphine Lissa, Karl Fraser, Nicholas M. Durham, Emily C. Jennings, Sonia Agrawal, Lily I. Cheng, Mark T. Esser, Jean Boyer, Marcelo Bonomi, Mercedes Porosnicu, Missak Haigentz, Tanguy Y. Seiwert, Ammar Sukari, Alain Algazi, Nabil F. Saba, Charu Aggarwal
Purpose:Tumoral programmed cell death ligand-1 (PD-L1) expression is common in human papillomavirus (HPV)–associated head and neck squamous cell carcinoma (HNSCC). We assessed whether a DNA vaccine targeting HPV-16/18 E6/E7 with IL12 adjuvant (MEDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491114b0233b1825295289b6616a2d15
https://doi.org/10.1158/1078-0432.c.6533137.v1
https://doi.org/10.1158/1078-0432.c.6533137.v1
Autor:
Charu Aggarwal, Nabil F. Saba, Alain Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T. Esser, Lily I. Cheng, Sonia Agrawal, Emily C. Jennings, Nicholas M. Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gascó Hernández, Rakesh Kumar
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 29, iss 3
Purpose: Tumoral programmed cell death ligand-1 (PD-L1) expression is common in human papillomavirus (HPV)–associated head and neck squamous cell carcinoma (HNSCC). We assessed whether a DNA vaccine targeting HPV-16/18 E6/E7 with IL12 adjuvant (MED
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d7dd3b4d6278c10d8b9948e138f327
https://escholarship.org/uc/item/3wz58697
https://escholarship.org/uc/item/3wz58697
Autor:
Alison E. Smith, Stacia Chan, Zhiyong Wang, Asako McCloskey, Quinn Reilly, Jayden Z. Wang, Hetika Vora Patel, Keiichi Koshizuka, Harris S. Soifer, Linda Kessler, Ashley Dayoub, Victoria Villaflor, Douglas Adkins, Justine Bruce, Alan Ho, Cesar Perez Batista, Glenn Hanna, Amaya Gascó Hernández, Andrew Saunders, Stephen Dale, J. Silvio Gutkind, Francis Burrows, Shivani Malik
Outcomes for patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) are poor, with median overall survival ranging from 6 to 18 months. For those who progress on standard of care (chemo)immunotherapy, treatment options
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09c5b042d1929c72d38919e6e5354710
https://doi.org/10.1101/2023.01.17.523964
https://doi.org/10.1101/2023.01.17.523964